The effects of intravenous clonidine and tizanidine on nociceptive neurons in the nucleus ventralis posterolateralis (VPL) of the thalamus, a key station in the lateral system of ascending pain pathways, were evaluated in urethane-chloralose anesthetized cats. Intravenous clonidine and tizanidine produced a dose-dependent (5 and 10 pg/kg, and 25 and 50 ,ug/kg, respectively) suppression of responses of nociceptive specific (NS) and wide dynamic range (WDR) neurons in the VPL to high threshold splanchnit input. In contrast, the responses of both NS and WDR units to electrical stimulation of spinothalamic tract fibers in the ventrolateral funiculus (VLF) were little affected. We conclude that a site of suppressive action of the qadrenoceptor agonists, as observed in nociceptive VPL neurons, is at the level of the spinal dorsal horn rather than in the VPL itself.
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(Anesth Analg 1995;81:259-64) S ystemic administration of clonidine produces analgesia (1,2) via a,-adrenergic agonism (3) . Tizanidine is a clonidine derivative with a,-adrenergic properties (4). Animal studies have shown that systemic clonidine and tizanidine can suppress spinal neuronal responses to noxious stimulation (5,6). Systemic a,-adrenoceptor agonists may be useful for some pain conditions in humans (7). Spinally administered clonidine can also produce antinociceptive effects on behavioral and spinal neuronal responses, indicating involvement of spinal mechanisms in antinociception (8,9). Clonidine provides analgesia when administered intrathecally and epidurally in humans (10,ll).
It has been reported that systemically administered medetomidine, another a,-adrenoceptor agonist, suppressed evoked responses of nociceptive intralaminar neurons in the medial thalamus, and a supraspinal qadrenergic mechanism has been suggested (12). There are no reports on effects of systemically applied cY,-adrenoceptor agonists on responses of nociceptive neurons in the thalamic ventrobasal (VB) complex, which is a key station in the lateral system of ascending pain pathways. Central poststroke pain has been suggested to be due to a deafferentation syndrome of the lateral ascending system (13). If so, effects on nociceptive neurons in the VB complex may be of importance. The present study was undertaken to study the effects of clonidine and tizanidine on evoked responses of nociceptive neurons in the nucleus ventralis posterolateralis (VPL) which is a component of the VB complex.
Methods
Experiments were performed on 43 adult cats weighing 2.5-4.0 kg. They were supplied by the Laboratory Animal Institute of our university and the protocol was approved by our Animal Care and Use Committee. Anesthesia was induced with ketamine HCl (20 "g/kg, intramuscularly), and the right cephalic vein was cannulated for drug administration, as was the right femoral artery for continuous monitoring of the blood pressure. Anesthesia was maintained by 3.5 mL/kg of urethane-chloralose solution (urethane 125 mg/mL and chloralose 10 mg/mL), which was intravenously (IV) administered in 10 min. Additional IV doses of urethane-chloralose solution (0.5 mL/kg) were given every 2 h. The esophageal temperature was monitored and maintained at 37 + 0.5"C by an electric heating pad under the abdomen and by an infrared lamp.
The left greater splanchnic nerve (SPL) was exposed retroperitoneally.
The exposed SPL was dissected free from surrounding tissues at the level just proximal to the coeliac ganglion. A bipolar platinum stimulating electrode was applied to the SPL, and held in position with a low-melting-point (39°C) paraffin.
A craniotomy was performed over the right VPL to allow access for microelectrode exploration. Via laminectomy, the spinal cord dorsum at the level of C3 and C4 was exposed, and a bipolar by IV pancuronium bromide (0.4 mg/kg).
The animal was artificially ventilated. End-tidal CO, was monitored and maintained at 3.5%-4.5%.
Recordings were made from single units in the VPL using glass microelectrodes filled with a 2% solution of Pontamine sky blue (Tokyo Kasei, Tokyo, Japan) in 0.5 M sodium acetate. The peripheral receptive field properties of VPL neurons were assessed using a variety of mechanical stimuli: gentle brushing, pressure applied to a fold of skin using a pair of broad-tipped forceps, and pinching with a pair of fine serrated forceps. The output of the oscilloscope on which the responses of single thalamic units were displayed was connected to a window discriminator that was connected to a spike counter. The output from the spike counter consisted of a count of the number of spikes in 1995;81:259-64 ANESTHETIC ACTIONS AND OUTCOMES HIRATA ET AL.
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each sequential l-s bin during a period of background, and both during and after mechanical stimulation of the cutaneous receptive field.
All units were tested for SPL input, and nociceptive units with SPL input were subjected to the study of effects of IV clonidine or tizanidine. Test stimuli were delivered either via the SPL or via the VLF at 1 Hz. The unit responses to the stimuli were displayed on a personal computer using a dot raster processing program QP-130J which we developed in cooperation with the Nihon Kohden Co. (Tokyo, Japan> and printed out after the experiment. The locations of the units studied were marked by extruding a small amount of Pontamine sky blue from the microelectrode tip electrophoretically (5 PA DC current passed for 10 min).
After each experiment, the VLF stimulation site was lesioned electrolytically, with a current of 2 mA for 2 min. Animals were then deeply anesthetized, and perfused with 1 L of a solution of 0.5% potassium ferrocyanide in normal saline, followed by 2 L of 10% formalin.
Serial sections (50~pm thick) were cut, stained with cresyl violet, and the locations of both the stimulation and recording sites were checked. Figure 1 . The threshold of response to the SPL stimulation was 1.0-4.4 X threshold for the reflex contraction of intercostal muscles measured prior to exploration. The intensity of the test stimulus was 2 X threshold for the unit discharges.
Effects of IV clonidine (10 pg/kg) on a NS unit are illustrated in Figure 2 . The unit was located in the ventral margin of the VPL and did not respond to brushing and pressure applied to the cutaneous receptive field, but showed sustained discharge when a noxious pinch was applied. Five minutes after the injection, the SPL response decreased to 16.6% of the control responses prior to the injection. The VLF response was 103.7% of the control. During and after injection, the blood pressure was temporarily increased but recovered in 3 min. 6, blood pressure record&g.
The mean time courses of changes in SPL and VLF responses are plotted in Figure 3 . In NS units, the maximum suppression of SPL response as observed 5 min after the administration was 41.8% t: 5.5% after 5 &kg administration, and 72.3% + 4.8%, after 10 pg/kg administration.
The difference was statistically significant.
The half-time was 27.4 min with 5 pg/kg and 35.5 min with 10 pglkg.
In WDR units, the maximum suppression of SPL response as observed 5 min after the administration was 29.8% 2 6.5% and 59.0% +-7.7% after 5 pg/kg and 10 pg/kg administration, respectively. The difference was statistically significant. The half-time was 26.0 min and 26.4 min after 5 pg/kg and 10 pg/kg, respectively.
In both NS and WDR units, IV clonidine did not produce any significant changes in VLF response.
Tizanidine was IV administered in a dose of 25 pg/kg or 50 pg/kg. Effects of 50 pg/kg tizanidine on a WDR unit recorded from the dorsal shell region of the VPL are illustrated in Figure 4 . The unit had a graded response to brushing, pressure, and noxious pinch applied to the center of the receptive field (black area in Figure 4A ), responding best to noxious pinch. Outside this zone (cross-hatched area in Figure 4A ), the unit was unresponsive to low intensity mechanical stimuli, but responded differentially to pressure and noxious pinch. Finally, the latter area was surrounded by an area in which only noxious pinch resulted in neuronal discharges (shaded area in Figure 4A ). The latency of SPL and VLF responses was 10.6-14.0 ms and 2.2-6.4 ms, respectively.
Five minutes after tizanidine (50 pg/kg) administration, SPL response was suppressed by 56%, while VLF response was 103% of the control. The blood pressure was temporarily increased during and after injection, but recovered in 3 min ( Figure 3D) .
The mean time courses of changes in SPL and VLF responses are plotted in Figure 5 . In NS units, the degree of maximum suppression as observed 5 min after 25 pg/kg administration was 42.1% ? 6.0%. It was 57.2% _C 4.1% after 50 pg/kg.
The half-time was 28.6 min and 27.8 min after 25 and 50 pg/kg, respectively.
In WDR units, the degree of maximum suppression as observed 10 min after 25 pg/kg administration was 44.2% f 5.1%. The half-time was 19.0 min. After administration of 50 pg/kg, the maximum suppression was 62.7% + 5.4%. The half-time was 27.8 min.
In both NS and WDR units, the difference in suppression of SPL response between two different doses was statistically significant. IV tizanidine did not produce any significant changes in VLF response of both units.
The effects of both clonidine and tizanidine on spontaneous discharges of nociceptive VPL units are summarized in Table 1 . Both clonidine and tizanidine had no significant effects.
Discussion
This study was performed under urethane-chloralose anesthesia. It is known that barbiturates markedly suppress thalamic-evoked responses.
Under chloralose, the responses are of the same type as those recorded from unanesthetized, sleeping animals. It was assumed that by using chloralose, we do not deal with a completely abnormal state of the animal, one which would be without functional significance (16 clinical application of clonidine is in the treatment of hypertension. Tizanidine is a centrally acting muscle relaxant with predominantly cu,-adrenergic properties (4). Many animal studies have demonstrated that systemically administered clonidine and tizanidine can suppress behavioral and spinal neuronal responses to noxious stimuli (l-5).
(Ye Agonists generally have sedative and antinociceptive properties (3, 21) . The sedative action may be dependent on supraspinal mechanisms. They also exert a suppressive action on nociceptive neurons in the intralaminar nuclei of the medial thalamus (12). These previous data indicate that (Y* agonists have supraspinal and spinal actions. The present study revealed that they suppress responses of nociceptive VPL neurons to SPL input, but have little effect on the transmission of spinothalamic input. Both NS and WDR units show spontaneous discharges (14,15), but the discharges were unaffected by the (~z agonists. There are only two synaptic relay stations between peripheral sensory receptors and VPL neurons, namely, one in the spinal cord and the other in the VPL. Thus the site of suppressive action of (Y*-adrenoceptor agonists as observed in nociceptive VPL neurons is at the level of the spinal dorsal horn rather than in the VPL itself. 
